Research published in Deutsches Arzteblatt International said infections are among the most frequent complications of a stay in a hospital in Germany, and they raise complication and mortality rates. Based on data from the Hospital Infection Surveillance System, the study showed an incidence of almost 60,000 newly acquired infections annually in Germany’s intensive care units. Christine Geffers of the Institut fur Hygiene und Umweltmedizin and co-author Petra Gastmeier also found that while the percentage of patients in intensive care who have methicillin-resistant Staphylococcus aureus species has been stable for years, the number with extended-spectrum beta-lactamase-producing E. coli and Klebsiella pneumoniae is increasing.

Researchers from the University of Chicago and colleagues concluded that many steps hospitals take to minimize the number of methicillin-resistant Staphylococcus aureus infections, including engaging in surveillance for MRSA colonization, are costly and can result in false-positive test results. According to the scientists, whose work was published in Infection Control and Hospital Epidemiology, the performance of this technique would be enhanced if patients who are at high risk for colonization could be easily targeted. The investigators studied 23,314 patients and came up with five MRSA prediction rules that could be used to identify the 30 percent of patients who account for approximately 70 percent of all MRSA-associated patient-days.

Chlorhexidine gluconate baths were more effective in reducing hospital-acquired infections than soap-and-water baths, according to a new study from Rhode Island Hospital. Researchers looked at a group of 7,699 adult patients who were bathed daily with CHG cloths, comparing the outcomes with those of a control group of 7,102 patients who were bathed with soap and water. Senior investigator Leonard Mermel said the results indicated a significant reduction in patients’ risk of developing an infection related to methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus.

Researchers have shown that stopping MRSA’s ability to degrade RNA can inhibit its spread, both in the laboratory and in infected mice, according to a report published in PLoS Pathogens. Scientists led by Paul Dunman of the University of Rochester Medical Center especially focused on RnpA, a molecule they found to be involved in the RNA degradation process. Specifically, the team isolated RNPA1000, and in tests on mice, 50 percent of those treated with a large dose of the molecule survived while all of the mice in the control group died. The scientists said inhibiting degradation might cause the bacteria to be overcome by an onslaught of confusing instructions that should have been turned off.

The Association for Professionals in Infection Control and Epidemiology has published a second edition of its "Guide to the Elimination of Methicillin-Resistant Staphylococcus aureus Transmission in Hospital Settings," updating the guidance with the most current evidence-based practice information available to prevent health care-associated infections. The revised guide updates and enhances the original APIC guide, which was published in 2007, adding references, resources, research findings and new guidance.

Pascale Hancart-Petitet of the Institut Pasteur du Cambodge in Phnom Penh, Cambodia, and colleagues reported in BMC Public Health on the social and cultural factors shaping hygiene practices in Cambodian health care settings. According to the researchers, the frequency of bloodborne pathogen-related infections is thought to be high in developing Southeast Asian countries, but the social-cultural logics contributing to the risks of transmission are rarely studied. The researchers conducted qualitative surveys of 319 participants and found that hygiene practices were burdened in part by a lack of adequate materials and equipment.

Researchers led by Andrew Barron and Qilin Li of Rice University have developed a new technique to make titanium dioxide, a common disinfectant, more effective. In their research, the scientists found that adding silicone to the disinfectant significantly increased its ability to degrade aerosol- and waterborne viruses. Using a very simple treatment, "we've improved [titanium dioxide's] performance by more than three times without any real cost," Barron said.

Placing intensive care unit patients in private rooms may help lower the risk of infection. In the study, Teltsch and colleagues analyzed data from 19,343 ICU admissions between 2000 and 2005 at two Montreal hospital centers, one of which switched to only private ICU rooms in March 2002. They found that the combined risk of a patient acquiring an infection such as MRSA, vancomycin-resistant Enterococcus species and Clostridium difficile dropped by 54 percent after the transition to private rooms. Additionally, the researchers found that the average patient in a private room stayed in the ICU 10 percent fewer days after the conversion.